Latest KFF Health News Stories
Going Down Fighting: Dying Activist Champions ‘Medicare For All’
Presidential hopeful Elizabeth Warren tried to tell the story of Ady Barkan in the latest Democratic debate. He’s one of the most prominent advocates for “Medicare for All” and is spending his remaining time alive doing everything he can to make the case that all Americans need affordable health coverage.
Trump Administration Hits Brakes On Law To Curb Unneeded Medicare CT Scans, MRIs
Critics worry the delays come at a steep cost: Medicare paying for millions of unnecessary exams and patients subject to radiation for no medical benefit.
Class-Action Lawsuit Seeks To Let Medicare Patients Appeal Gap in Nursing Home Coverage
Medicare beneficiaries under observation care in the hospital can face higher costs for treatment and are not covered for nursing home care when discharged. A federal trial in Hartford, Conn., will determine whether the government’s ban on appeals involving observation care coverage is fair.
Infusion Treatments — Needed or Not — Can Deplete Patients’ Wallets
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren’t aware of cheaper options.
KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
Biden-Harris Debate Rematch Highlights Health Plan Differences
The Wednesday night event marked the second night in a row for Democratic presidential hopefuls to stake claims on how to fix the health care system.
La revancha del debate Biden-Harris destaca diferencias en los planes de salud
Hay casi tantas versiones de “Medicare para Todos” como candidatos demócratas, y cada uno piensa que su plan es el camino para asegurar a todos los estadounidenses.
Trump Administration Moves To Make Health Care Costs More Transparent
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.
Genetic-Testing Scam Targets Seniors And Rips Off Medicare
Capitalizing on the growing popularity of genetic testing — and fears of terminal illness — scammers are persuading seniors to hand over cheek swabs with their DNA, not knowing it may lead to identity theft and Medicare fraud.
In A Messy Democratic Presidential Debate, Facts About ‘Medicare For All’ Get Tossed About
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
Democrats Favor Building On ACA Over ‘Medicare For All’
Asked to choose between building on the Affordable Care Act and replacing it with a national Medicare for All plan, 55% of Democrats and Democratic-leaning independents said they would expand the existing law, according to a Kaiser Family Foundation poll released Tuesday.
Klobuchar Says D.C. Has Enough Drug Lobbyists To Double-Team Lawmakers
The drug industry has the biggest lobbying war chest.
GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.
KHN’s ‘What The Health?’: Cue The Drug Price Debate
Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.
Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
¿Quieres retirarte y vivir en el exterior? Medicare no viaja muy bien
De 2012 a 2017, el número de trabajadores jubilados que vivían en países extranjeros y que recibían beneficios del Seguro Social creció casi un 15%, a más de 413,000, según la Administración del Seguro Social.
Federal Suit Alleges ‘Staggering’ Urine Drug Testing Fraud At Tennessee Pain Clinics
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
Dream Of Retiring Abroad? The Reality: Medicare Doesn’t Travel Well
More than 400,000 U.S. workers have retired in foreign countries and their ranks are rising. But Medicare doesn’t cover most expenses overseas, so these expats will need to confront the cost of finding alternative insurance.
Missouri Firm With Silicon Valley Ties Faces Medicare Billing Scrutiny
Amid an overall crackdown on private insurers’ Medicare billing practices, a new government audit and a whistleblower suit allege St. Louis-based Essence Group Holdings Corp.’s Medicare Advantage plans overcharged taxpayers.
A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant
Banking on new cost estimates, a bipartisan coalition in Congress is poised to try — once again — to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.
